Cargando…

Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model

BACKGROUND: A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/...

Descripción completa

Detalles Bibliográficos
Autores principales: Neilan, John G., Schutta, Christopher, Barrera, José, Pisano, Melia, Zsak, Laszlo, Hartwig, Ethan, Rasmussen, Max V., Kamicker, Barbara J., Ettyreddy, Damodar, Brough, Douglas E., Butman, Bryan T., Brake, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114537/
https://www.ncbi.nlm.nih.gov/pubmed/30157853
http://dx.doi.org/10.1186/s12917-018-1582-1
_version_ 1783351212725239808
author Neilan, John G.
Schutta, Christopher
Barrera, José
Pisano, Melia
Zsak, Laszlo
Hartwig, Ethan
Rasmussen, Max V.
Kamicker, Barbara J.
Ettyreddy, Damodar
Brough, Douglas E.
Butman, Bryan T.
Brake, David A.
author_facet Neilan, John G.
Schutta, Christopher
Barrera, José
Pisano, Melia
Zsak, Laszlo
Hartwig, Ethan
Rasmussen, Max V.
Kamicker, Barbara J.
Ettyreddy, Damodar
Brough, Douglas E.
Butman, Bryan T.
Brake, David A.
author_sort Neilan, John G.
collection PubMed
description BACKGROUND: A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7 days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers. RESULTS: In Efficacy Study 1, we evaluated three doses of AdtA24 to estimate the 50%/90% bovine protective dose (BPD(50/90)) for prevention of clinical FMD. In vaccinated, contact-challenged steers, the BPD(50/90) was 3.1 × 10(10) / 5.5 × 10(10) AdtA24 particles formulated without adjuvant. In Efficacy Study 2, steers vaccinated with 5 × 10(10) AdtA24 particles, exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers, did not develop clinical FMD or transmit FMDV to other vaccinated or naïve, non-vaccinated steers. In contrast, naïve, non-vaccinated steers that were subsequently exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers developed clinical FMD and transmitted FMDV by contact to additional naïve, non-vaccinated steers. The AdtA24 vaccine differentiated infected from vaccinated animals (DIVA) because no antibodies to FMDV nonstructural proteins were detected prior to FMDV exposure. CONCLUSIONS: A single dose of the AdtA24 non-adjuvanted vaccine conferred protection against clinical FMD at 7 days post-vaccination following direct contact transmission from FMDV-infected, naïve, non-vaccinated steers. The AdtA24 vaccine was effective in preventing FMDV transmission from homologous challenged, contact-exposed, AdtA24-vaccinated, protected steers to co-mingled, susceptible steers, suggesting that the vaccine may be beneficial in reducing both the magnitude and duration of a FMDV outbreak in a commercial cattle production setting.
format Online
Article
Text
id pubmed-6114537
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61145372018-09-04 Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model Neilan, John G. Schutta, Christopher Barrera, José Pisano, Melia Zsak, Laszlo Hartwig, Ethan Rasmussen, Max V. Kamicker, Barbara J. Ettyreddy, Damodar Brough, Douglas E. Butman, Bryan T. Brake, David A. BMC Vet Res Research Article BACKGROUND: A direct contact transmission challenge model was used to simulate natural foot-and-mouth disease virus (FMDV) spread from FMDV A24/Cruzeiro/BRA/55 infected ‘seeder’ steers to naïve or vaccinated steers previously immunized with a replication-deficient human adenovirus-vectored FMDV A24/Cruzeiro/BRA/55 capsid-based subunit vaccine (AdtA24). In two independent vaccine efficacy trials, AdtA24 was administered once intramuscularly in the neck 7 days prior to contact with FMDV A24/Cruzeiro/BRA/55-infected seeder steers. RESULTS: In Efficacy Study 1, we evaluated three doses of AdtA24 to estimate the 50%/90% bovine protective dose (BPD(50/90)) for prevention of clinical FMD. In vaccinated, contact-challenged steers, the BPD(50/90) was 3.1 × 10(10) / 5.5 × 10(10) AdtA24 particles formulated without adjuvant. In Efficacy Study 2, steers vaccinated with 5 × 10(10) AdtA24 particles, exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers, did not develop clinical FMD or transmit FMDV to other vaccinated or naïve, non-vaccinated steers. In contrast, naïve, non-vaccinated steers that were subsequently exposed to FMDV A24/Cruzeiro/BRA/55-infected seeder steers developed clinical FMD and transmitted FMDV by contact to additional naïve, non-vaccinated steers. The AdtA24 vaccine differentiated infected from vaccinated animals (DIVA) because no antibodies to FMDV nonstructural proteins were detected prior to FMDV exposure. CONCLUSIONS: A single dose of the AdtA24 non-adjuvanted vaccine conferred protection against clinical FMD at 7 days post-vaccination following direct contact transmission from FMDV-infected, naïve, non-vaccinated steers. The AdtA24 vaccine was effective in preventing FMDV transmission from homologous challenged, contact-exposed, AdtA24-vaccinated, protected steers to co-mingled, susceptible steers, suggesting that the vaccine may be beneficial in reducing both the magnitude and duration of a FMDV outbreak in a commercial cattle production setting. BioMed Central 2018-08-29 /pmc/articles/PMC6114537/ /pubmed/30157853 http://dx.doi.org/10.1186/s12917-018-1582-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Neilan, John G.
Schutta, Christopher
Barrera, José
Pisano, Melia
Zsak, Laszlo
Hartwig, Ethan
Rasmussen, Max V.
Kamicker, Barbara J.
Ettyreddy, Damodar
Brough, Douglas E.
Butman, Bryan T.
Brake, David A.
Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
title Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
title_full Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
title_fullStr Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
title_full_unstemmed Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
title_short Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model
title_sort efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype a subunit vaccine in cattle using a direct contact transmission model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114537/
https://www.ncbi.nlm.nih.gov/pubmed/30157853
http://dx.doi.org/10.1186/s12917-018-1582-1
work_keys_str_mv AT neilanjohng efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT schuttachristopher efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT barrerajose efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT pisanomelia efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT zsaklaszlo efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT hartwigethan efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT rasmussenmaxv efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT kamickerbarbaraj efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT ettyreddydamodar efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT broughdouglase efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT butmanbryant efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel
AT brakedavida efficacyofanadenovirusvectoredfootandmouthdiseasevirusserotypeasubunitvaccineincattleusingadirectcontacttransmissionmodel